Atrial fibrillation raises stroke risk fivefold. But what if blood thinners are too dangerous after a brain bleed or major fall? A new monthly injection, abelacimab, may prevent strokes without the bleeding risk of traditional anticoagulants. Is this the future for AFib patients who can’t take blood thinners? Cardiologist Dr. Alain Bouchard discusses this groundbreaking drug with Dr. Charles V. Pollack, a consultant clinical scientist and professional educator with Novartis, owner of abelac...
All content for MyHeart.net is the property of Dr. Alain Bouchard and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Atrial fibrillation raises stroke risk fivefold. But what if blood thinners are too dangerous after a brain bleed or major fall? A new monthly injection, abelacimab, may prevent strokes without the bleeding risk of traditional anticoagulants. Is this the future for AFib patients who can’t take blood thinners? Cardiologist Dr. Alain Bouchard discusses this groundbreaking drug with Dr. Charles V. Pollack, a consultant clinical scientist and professional educator with Novartis, owner of abelac...
Beyond Blood Thinners: Rethinking Stroke Prevention in AFib with Dr. Charles V. Pollack
MyHeart.net
51 minutes
1 month ago
Beyond Blood Thinners: Rethinking Stroke Prevention in AFib with Dr. Charles V. Pollack
Atrial fibrillation raises stroke risk fivefold. But what if blood thinners are too dangerous after a brain bleed or major fall? A new monthly injection, abelacimab, may prevent strokes without the bleeding risk of traditional anticoagulants. Is this the future for AFib patients who can’t take blood thinners? Cardiologist Dr. Alain Bouchard discusses this groundbreaking drug with Dr. Charles V. Pollack, a consultant clinical scientist and professional educator with Novartis, owner of abelac...
MyHeart.net
Atrial fibrillation raises stroke risk fivefold. But what if blood thinners are too dangerous after a brain bleed or major fall? A new monthly injection, abelacimab, may prevent strokes without the bleeding risk of traditional anticoagulants. Is this the future for AFib patients who can’t take blood thinners? Cardiologist Dr. Alain Bouchard discusses this groundbreaking drug with Dr. Charles V. Pollack, a consultant clinical scientist and professional educator with Novartis, owner of abelac...
